FMI suggests the hydrolyzed egg membrane market was valued at USD 180.0 million in 2025, increased to USD 200.0 million in 2026, and is projected to reach USD 675.0 million by 2036, reflecting a 12.9% CAGR during 2026 to 2036. By segment, joint health & mobility supplements lead the application category with a 44% share in 2026, while powder/flakes dominate the form segment with a 52% share in 2026.